Increased Survival of Cirrhotic Patients with a Hepatocellular Carcinoma Detected during Surveillance

Gastroenterology

Volumn 126, Issue 4, 2004, Pages 1005-1014

  Sangiovanni, Angelo ^a   Del Ninno, Ersilio ^a   Fasani, Pierangelo ^a   De Fazio, Cristina ^a   Ronchi, Guido ^a   Romeo, Raffaella ^a   Morabito, Alberto ^a   De Franchis, Roberto ^a   Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; ULTRASOUND;

EID: 1842426695     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.12.049     Document Type: Article

References (29)

1. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodēs J, for the EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona EASL Conference. J Hepatol 2001;35:421-430.
2. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K. Prospective study of yearly detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-687.
3. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
4. Pateron D, Ganne N, Trinchet IC, Aurronssean MH, Mal F, Meicher C, Coderc E, Reboullet P, Beaugrand M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
5. Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977-985,
6. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-335.
7. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;482:251-259.
8. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS, Duffy SW. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002;98:257-261.
9. The Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-2780.
10. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
11. Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 2000;31:1019-1021.
12. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210: 655-661.
13. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodes J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1022.
14. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
15. Romeo R, Thiers V, Driss F, Berthelot P, Nalpas B, Brechot C. Hepatitis C virus (HCV) RNA in serum and peripheral blood mononuclear cells (PBMC) of blood donors with and without elevated aminotransferase activity. Transfusion 1993;33:629-633.
16. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1102.
17. Portal hypertension III. Proceedings of third Baveno International Consensus Workshop on Definition, Methodology and Therapeutic Strategies. de Franchis R, ed. London: Blackwell Science, 2001:1-247.
18. Salerno F, Angeli P, Bernardi M, Laffi G, Riggio O, Salvagnini M. Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver. Ital J Gastroenterol Hepatol 1999; 7:626-634.
19. Peters RL. Pathology of hepatocellular carcinoma, In: Okuda K, Peters RL, eds. Hepatocellular carcinoma. New York: John Wiley, 1976:107-168.
20. Borzio M, Borzio F, Croce A, Sala M, Salmi A, Leandro G, Bruno S, Roncalli M. Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study, Gastroenterology 1997; 112:1617-1623.
21. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993;67:773-775.
22. Saccheri S, Lovaria A, Sangiovanni A, Nicolini A, De Fazio C, Ronchi G, Fasani P, Del Ninno E, Colombo M. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. J Vasc Interv Radiol 2002;13:995-999.
23. CLIP investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators, Hepatology 1998; 28:751-755.
24. Fujita M, Kuroda C, Kumatani T, Yoshioka H, Kuriyama K, Inoue E, Kasugai H, Sasaki Y. Comparison between conventional and spiral CT in patients with hypervascular hepatocellular carcinoma. Eur J Radiol 1994;18:134-136.
25. Ganne-Carriè N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Dény P, Trinchet JC, Callard P, Guettier C, Beaugrand M. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23:1112-1118.
26. Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, Sotorríos NG, Marténez I, Rodrigo L. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003;37:520-527.
27. Ballardini G, Groff P, Zoli M, Bianchi GB, Giostra F, Francesconi R, Lenzi M, Zauli D, Cassani F, Bianchi F. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J Hepatol 1994;20:218-222.
28. Donato MF, Arosio E, Del Ninno E, Ronchi G, Lampertico P, Morabito A, Balestrieri MR, Colombo M. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 2001;34:523-528.
29. Bruix J, Llovet JM. HCC surveillance: who is the target population? Hepatology 2003;37:507-509.